EVOLVA BIOTECH A/S: Financial statements 2014
CVR: 25532538
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
EVOLVA BIOTECH A/S (CVR 25532538) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 39,427,869 and a net result of DKK 1,828,462 compared with DKK -1,155,567 the year before. That is an increase of 46.1% compared with the year before. The profit margin was 4.6%. Equity in the 2014 report amounted to DKK 8,916,800. The solvency ratio was 30.5%.
- Revenue
- DKK 39,427,869
- Gross Profit
- DKK 28,405,493
- Profit/Loss
- DKK 1,828,462
- Equity
- DKK 8,916,800
- Total Assets
- DKK 29,274,359
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 39.4 mio. | 28.4 mio. | 1.8 mio. | 8.9 mio. | - |
| 2013 | 27 mio. | 18.9 mio. | -1.2 mio. | 7.1 mio. | - |
| 2012 | 19.1 mio. | 12.6 mio. | -2 mio. | 8.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 31, 2014, Bo Danner Henriksen has joined the board of directors of EVOLVA BIOTECH A/S.
As of October 31, 2014, Neil Goldsmith has left the board of directors of EVOLVA BIOTECH A/S.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of EVOLVA BIOTECH A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of EVOLVA BIOTECH A/S.
EVOLVA BIOTECH A/S has published its annual report for 2013. Revenue came to DKK 26,987,702, and the net result was DKK -1,155,567.
About EVOLVA BIOTECH A/S
EVOLVA BIOTECH A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 2000. The company has been dissolved on 17 June 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ARPIDA A/S and COMBIO A/S. The company has 2 employees (2018). In 2020, the company reported a gross profit of DKK -116,208 and a net result of DKK -196,806 compared with DKK -187,015 the year before. Equity in the 2020 report amounted to DKK 6,378,584.